Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4469-4476, Vol. 67, No. 9
Departments of Cell
Biology,1
Medicine,2 and Microbiology and
Immunology,3 Albert Einstein College of
Medicine, Bronx, New York 10461
Received 31 March 1999/Returned for modification 17 May
1999/Accepted 18 June 1999
The antibody response to Cryptococcus neoformans
capsular glucuronoxylomannan (GXM) in BALB/c mice frequently expresses
the 2H1 idiotype (Id) and is restricted in variable gene usage. This study examined the immunogenicity of GXM-protein conjugates, V (variable)-region usage, and 2H1 Id expression in seven mouse strains:
BALB/c, C57BL/6, A/J, C3H, NZB, NZW, and (NZB × NZW)F1 (NZB/W). All mouse strains responded to vaccination
with GXM conjugated to tetanus toxoid (TT), the relative magnitude of
the antibody response being BALB/c ~ C3H > C57BL/6 ~ NZB ~ NZW ~ NZB/W > A/J. Analysis of serum
antibody responses to GXM with polyclonal and monoclonal antibodies to
the 2H1 Id revealed significant inter- and intrastrain differences in
idiotype expression. Thirteen monoclonal antibodies (MAbs) (two
immunoglobulin M [IgM], three IgG3, one IgG1, three IgG2a, two IgG2b,
and two IgA) to GXM were generated from one NZB/W mouse and one C3H/He
mouse. The MAbs from the NZB/W mouse were all 2H1 Id positive
(Id+) and structurally similar to those previously
generated in BALB/c mice, including the usage of a VH from
the 7183 family and V
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Molecular and Idiotypic Analyses of the Antibody
Response to Cryptococcus neoformans
Glucuronoxylomannan-Protein Conjugate Vaccine in Autoimmune and
Nonautoimmune Mice
5.1. Administration of both 2H1 Id+
and Id
MAbs from NZB/W and C3H/H3 mice prolonged survival
in a mouse model of cryptococcosis. Our results demonstrate (i) that
V-region restriction as indicated by the 2H1 Id is a feature of both
primary and secondary responses of several mouse strains; and (ii) that there is conservation of V-region usage and length of the third complementarity-determining region in antibodies from three mouse strains. The results suggest that V-region restriction is a result of
antibody structural requirements necessary for binding an
immunodominant antigen in GXM.
*
Corresponding author. Mailing address for Arturo
Casadevall: Department of Medicine, Albert Einstein College of
Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718)
430-4259. Fax: (718) 430-8968. E-mail:
casadeva{at}aecom.yu.edu. Mailing address for Matthew D. Scharff: Department of Cell Biology, Albert Einstein College of
Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Phone: (718)
430-3504. Fax: (718) 430-8574. E-mail:
Scharff{at}aecom.yu.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»